Lung - Infiltration Cellular, Histiocyte





comment:
Responses to inhaled toxicants often include the accumulation of alveolar macrophages within alveoli. Accumulation of alveolar macrophages is also part of the response to necrosis and may be associated with pulmonary neoplasms or alveolar/bronchiolar hyperplasia. Focal histiocytic infiltrates may be observed spontaneously, most often in subpleural regions of older animals. Alveolar histiocytic infiltrates consist of intra-alveolar accumulations of macrophages. The macrophages can appear activated (enlarged with foamy cytoplasm) or quiescent. Though the lesion is often limited to the accumulation of alveolar macrophages ( Figure 1







Histiocytic infiltration must be differentiated from inflammation, which can sometimes be difficult. In general, histiocytic infiltration is characterized by increased numbers of alveolar histiocytes with no (or minimal) other evidence of inflammation (e.g., the presence of other types of inflammatory cells, edema, hemorrhage, alveolar septal thickening).
recommendation:
Lung - Infiltration cellular, Histiocyte should be diagnosed and given a severity grade in most cases. If the histiocytes contain the test agent, it should be diagnosed and graded separately foreign material (see Lung - Foreign Material). If the alveolar macrophages are considered to be a component of an inflammatory response, then inflammation should be diagnosed in lieu of histiocytic infiltration. Accumulations of alveolar histiocytes that are clearly associated with a neoplasm should not be recorded but should be described in the narrative as being secondary to the neoplasm. Small, subpleural accumulations of alveolar macrophages are frequently seen as background lesions in rats. If histiocytic infiltration is a diffuse change related to test article administration, and focal, subpleural (background) aggregates might skew incidence statistics, then either the non-test-article-related subpleural foci in chronic studies should not be recorded (i.e., considered to be within normal limits), or they may be recorded separately using modifier (e.g., Infiltration cellular, Histiocyte, Focal or Infiltration cellular, Histiocyte, Diffuse). In some cases, it may be best to diagnose both lesions. For example, if there is a continuum from alveolar histiocyte infiltration (with no inflammatory changes) in the low-dose groups to alveolar histiocyte infiltration with areas of inflammation in the high-dose groups, then it may be necessary to diagnose both lesions to fully capture the effects of the test article. The pathologist will need to use his or her judgment in recording these lesions and must take care to maintain consistency throughout the study.related links:
Lung - Foreign Materialreferences:
Boorman GA, Eustis SL. 1990. Lung. In: Pathology of the Fischer Rat: Reference and Atlas (Boorman GA, Eustis SL, Elwell MR, Montgomery CA, MacKenzie WF, eds). Academic Press, San Diego, CA, 339-367.
Dixon D, Herbert RA, Sills RC, Boorman GA. 1999. Lungs, pleura, and mediastinum. In: Pathology of the Mouse: Reference and Atlas (Maronpot RR, Boorman GA, Gaul BW, eds). Cache River Press, Vienna, IL, 293-332.
Renne, R, Brix A, Harkema J, Herbert R, Kittle B, Lewis D, March T, Nagano K, Pino M, Rittinghausen S, Rosenbruch M, Tellier P, Wohrmann T. 2009. Proliferative and nonproliferative lesions of the rat and mouse respiratory tract. Toxicol Pathol 37(suppl):5S-73S. Abstract: https://www.ncbi.nlm.nih.gov/pubmed/20032296
Web page last updated on: December 03, 2015